Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kjetil Boye

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
The Journal of Pathology|August 5, 2003
Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancerKjersti Flatmark, Kjetil Boye Pedersen, Jahn M Nesland, et al.
Pediatric Blood & Cancer|November 21, 2013
High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: final results of the ISG/SSG II studyKjetil Boye, Adalberto Brach Del Prever, Mikael Eriksson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2014
High expression of the cysteine proteinase legumain in colorectal cancer - implications for therapeutic targetingMads H Haugen, Kjetil Boye, Jahn Martin Nesland, et al.
Acta Oncologica (Stockholm, Sweden)|June 14, 2022
Real-world evidence on perioperative chemotherapy in localized soft tissue sarcoma of the extremities and trunk wall; a population-based studyKjetil Boye, Ingvild Lobmaier, Marthe Rosvoll Kobbeltvedt, et al.
Oncotarget|March 14, 2022
Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneityLudmila Gorunova, Kjetil Boye, Ioannis Panagopoulos, et al.
JCO Precision Oncology|February 1, 2023
Genomic Complexity as a Biomarker to De-Escalate Adjuvant Imatinib Treatment in High-Risk Gastrointestinal Stromal TumorKjetil Boye, Ludmila Gorunova, Bastian Gunawan, et al.
BMC Cancer|November 13, 2013
Osteopontin is a prognostic biomarker in non-small cell lung cancerAne Kongsgaard, Kjetil Boye, Miriam Oijordsbakken, et al.
Cancers|December 23, 2023
Diagnostics and Treatment of Extrameningeal Solitary Fibrous TumorsAnna Maria Janik, Anna Terlecka, Mateusz J Spałek, et al.
The British Journal of Surgery|September 27, 2023
Long-term outcome after surgical resection of non-high-risk gastrointestinal stromal tumours without adjuvant therapyMarta Berndsen, Sara Renberg, Toto Hølmebakk, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 3, 2018
Ivar Hompland, Toto Hølmebakk, Kjetil Boye, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
The Journal of Pathology|August 5, 2003
Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancerKjersti Flatmark, Kjetil Boye Pedersen, Jahn M Nesland, et al.
Pediatric Blood & Cancer|November 21, 2013
High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: final results of the ISG/SSG II studyKjetil Boye, Adalberto Brach Del Prever, Mikael Eriksson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2014
High expression of the cysteine proteinase legumain in colorectal cancer - implications for therapeutic targetingMads H Haugen, Kjetil Boye, Jahn Martin Nesland, et al.
Acta Oncologica (Stockholm, Sweden)|June 14, 2022
Real-world evidence on perioperative chemotherapy in localized soft tissue sarcoma of the extremities and trunk wall; a population-based studyKjetil Boye, Ingvild Lobmaier, Marthe Rosvoll Kobbeltvedt, et al.
Oncotarget|March 14, 2022
Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneityLudmila Gorunova, Kjetil Boye, Ioannis Panagopoulos, et al.
JCO Precision Oncology|February 1, 2023
Genomic Complexity as a Biomarker to De-Escalate Adjuvant Imatinib Treatment in High-Risk Gastrointestinal Stromal TumorKjetil Boye, Ludmila Gorunova, Bastian Gunawan, et al.
BMC Cancer|November 13, 2013
Osteopontin is a prognostic biomarker in non-small cell lung cancerAne Kongsgaard, Kjetil Boye, Miriam Oijordsbakken, et al.
Cancers|December 23, 2023
Diagnostics and Treatment of Extrameningeal Solitary Fibrous TumorsAnna Maria Janik, Anna Terlecka, Mateusz J Spałek, et al.
The British Journal of Surgery|September 27, 2023
Long-term outcome after surgical resection of non-high-risk gastrointestinal stromal tumours without adjuvant therapyMarta Berndsen, Sara Renberg, Toto Hølmebakk, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 3, 2018
Ivar Hompland, Toto Hølmebakk, Kjetil Boye, et al.
Pageof 8